Proposed criteria for specific and non-specific chromosomal genotoxicity based on hydrophobic interactions

Susanne B Dorn1, Gisela H Degen, Tina Müller

  • 1Institut für Arbeitsphysiologie an der Universität Dortmund, Ardeystr. 67, D-44139 Dortmund, Germany.

Mutation Research
|February 13, 2007
PubMed

Insights

This study differentiates specific and non-specific genotoxicity by analyzing chemical lipophilicity and its effect on cell division. Compounds with specific mechanisms of action were identified as outliers from the general lipophilicity rule, aiding safety assessment.

Area of Science:

  • Toxicology
  • Genetics
  • Cell Biology

Background:

  • Chromosomal damage tests are crucial for genotoxicity assessment and product safety.
  • Hydrophobic interactions influence cytokinesis, affecting the induction of bi- and multi-nucleated cells.
  • Previous research separated non-specific agents from specific inducers based on lipophilicity.

Purpose of the Study:

  • To broaden the concept of lipophilicity-based separation of genotoxic agents.
  • To include aneugenic and clastogenic compounds within the micronucleus (MN) test framework.
  • To develop a general procedure for screening specific and non-specific modes of action in chemical product development.

Main Methods:

  • Combined three datasets (A, B, C) of genotoxicity studies in V79 cells.
  • Investigated 33 compounds across a lipophilicity range (logP: -0.51 to 5.65).
  • Applied robust regression to separate compounds with specific modes of action from those with non-specific, lipophilicity-related genotoxicity.

Main Results:

  • All compounds with specific modes of action were identified as statistical outliers of the lipophilicity rule.
  • Non-specific genotoxicity was strongly correlated with hydrophobic interactions.
  • Genistein, a weak clastogen, approached the borderline between specific and non-specific genotoxicity.

Conclusions:

  • Lipophilicity serves as a predictor to distinguish between specific and non-specific genotoxic mechanisms.
  • The proposed method can effectively screen compounds for their mode of action in genotoxicity testing.
  • This approach supports safety assessment and product development by identifying potential genotoxic risks.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).